MS4A8 | Membrane-spanning 4-domains, subfamily A, member 8 | Predicted membrane proteins
| | | | | Group enriched |
REG1A | Regenerating islet-derived 1 alpha | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
SLC13A2 | Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC17A4 | Solute carrier family 17, member 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC7A9 | Solute carrier family 7 (amino acid transporter light chain, bo,+ system), member 9 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
ACE | Angiotensin I converting enzyme | Candidate cardiovascular disease genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
BEST4 | Bestrophin 4 | Predicted membrane proteins
| | | | | Group enriched |
CDHR2 | Cadherin-related family member 2 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CFTR | Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
DGAT1 | Diacylglycerol O-acyltransferase 1 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
FABP1 | Fatty acid binding protein 1, liver | Cancer-related genes Plasma proteins
| | | | | Group enriched |
FCGBP | Fc fragment of IgG binding protein | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
KRT20 | Keratin 20 | Plasma proteins
| | | | | Group enriched |
MUC13 | Mucin 13, cell surface associated | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
MUC2 | Mucin 2, oligomeric mucus/gel-forming | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
PCK2 | Phosphoenolpyruvate carboxykinase 2 (mitochondrial) | Citric acid cycle related proteins Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Group enriched |
SLC9A3 | Solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SPINK4 | Serine peptidase inhibitor, Kazal type 4 | Predicted secreted proteins
| | | | | Group enriched |
SULT1B1 | Sulfotransferase family, cytosolic, 1B, member 1 | Plasma proteins
| | | | | Group enriched |
TMEM253 | Transmembrane protein 253 | Predicted membrane proteins
| | | | | Group enriched |
ACY1 | Aminoacylase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Group enriched |
ANPEP | Alanyl (membrane) aminopeptidase | CD markers Enzymes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
CDX2 | Caudal type homeobox 2 | Cancer-related genes Transcription factors
| | | | | Group enriched |
DHDH | Dihydrodiol dehydrogenase (dimeric) | Enzymes
| | | | | Group enriched |
ENPEP | Glutamyl aminopeptidase (aminopeptidase A) | CD markers Enzymes Plasma proteins
| | | | | Group enriched |
ITLN2 | Intelectin 2 | Predicted secreted proteins
| | | | | Group enriched |
MGAM | Maltase-glucoamylase (alpha-glucosidase) | Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
MUC17 | Mucin 17, cell surface associated | Cancer-related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
PIGR | Polymeric immunoglobulin receptor | Cancer-related genes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
PLCB3 | Phospholipase C, beta 3 (phosphatidylinositol-specific) | Enzymes
| | | | | Group enriched |
REG4 | Regenerating islet-derived family, member 4 | Predicted secreted proteins
| | | | | Group enriched |
SST | Somatostatin | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
SULT1A2 | Sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2 | Enzymes
| | | | | Group enriched |
USH1C | Usher syndrome 1C (autosomal recessive, severe) | Cancer-related genes Cytoskeleton related proteins Disease related genes
| | | | | Group enriched |
ABCG2 | ATP-binding cassette, sub-family G (WHITE), member 2 | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
ACE2 | Angiotensin I converting enzyme 2 | Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
ACY3 | Aspartoacylase (aminocyclase) 3 | Enzymes
| | | | | Tissue enhanced |
AGR3 | Anterior gradient 3 | Predicted secreted proteins
| | | | | Tissue enhanced |
AKR1B10 | Aldo-keto reductase family 1, member B10 (aldose reductase) | | | | | | Tissue enhanced |
ANXA13 | Annexin A13 | Plasma proteins
| | | | | Tissue enhanced |
B3GALT5 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 | Predicted secreted proteins
| | | | | Tissue enhanced |
C1orf106 | Chromosome 1 open reading frame 106 | | | | | | Tissue enhanced |
CDHR5 | Cadherin-related family member 5 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CLDN3 | Claudin 3 | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
CYP4F12 | Cytochrome P450, family 4, subfamily F, polypeptide 12 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
DAB1 | Dab, reelin signal transducer, homolog 1 (Drosophila) | | | | | | Tissue enhanced |
DDC | Dopa decarboxylase (aromatic L-amino acid decarboxylase) | Disease related genes Enzymes FDA approved drug targets
| | | | | Tissue enhanced |
DPEP1 | Dipeptidase 1 (renal) | Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
DPP4 | Dipeptidyl-peptidase 4 | CD markers Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
EPCAM | Epithelial cell adhesion molecule | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |